Our top pick for
Beginners
Finder Award
BioXcel Therapeutics Inc is a biotechnology business based in the US. BioXcel Therapeutics shares (BTAI) are listed on the NASDAQ and all prices are listed in US Dollars. BioXcel Therapeutics employs 89 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in BioXcel Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BTAI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
BioXcel Therapeutics stock price (NASDAQ: BTAI)
Use our graph to track the performance of BTAI stocks over time.BioXcel Therapeutics shares at a glance
Information last updated 2022-06-25.
| Latest market close | $12.42 |
|---|---|
| 52-week range | $8.80 - $36.49 |
| 50-day moving average | $12.29 |
| 200-day moving average | $20.43 |
| Wall St. target price | $57.60 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-4.11 |
Buy BioXcel Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy BioXcel Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BioXcel Therapeutics price performance over time
Historical closes compared with the close of $12.42 from 2022-06-28
| 1 week (2022-06-22) | 10.89% |
|---|---|
| 1 month (2022-05-25) | N/A |
| 3 months (2022-03-25) | -43.44% |
| 6 months (2021-12-29) | -41.88% |
| 1 year (2021-06-29) | -59.45% |
|---|---|
| 2 years (2020-06-29) | -75.53% |
| 3 years (2019-06-28) | 13.32% |
| 5 years (2017-06-25) | N/A |
BioXcel Therapeutics financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -34.04% |
| Return on equity TTM | -58.84% |
| Profit margin | 0% |
| Book value | $6.93 |
| Market capitalisation | $338.9 million |
TTM: trailing 12 months
BioXcel Therapeutics share dividends
We're not expecting BioXcel Therapeutics to pay a dividend over the next 12 months.
BioXcel Therapeutics share price volatility
Over the last 12 months, BioXcel Therapeutics's shares have ranged in value from as little as $8.795 up to $36.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioXcel Therapeutics's is 1.3048. This would suggest that BioXcel Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
BioXcel Therapeutics overview
BioXcel Therapeutics, Inc. , a clinical stage biopharmaceutical company, utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic receptor agonist dexmedetomidine for the treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immune activator for the treatment of prostate and pancreatic cancers, and solid tumors. BioXcel Therapeutics, Inc. has a collaboration with collaboration with the VA Connecticut Healthcare System and the Yale University Medical School for patients suffering from post-traumatic stress disorder related to alcohol and substance abuse disorder. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut. .
Frequently asked questions
What percentage of BioXcel Therapeutics is owned by insiders or institutions?Currently 32.272% of BioXcel Therapeutics shares are held by insiders and 52.624% by institutions. How many people work for BioXcel Therapeutics?
Latest data suggests 89 work at BioXcel Therapeutics. When does the fiscal year end for BioXcel Therapeutics?
BioXcel Therapeutics's fiscal year ends in December. Where is BioXcel Therapeutics based?
BioXcel Therapeutics's address is: 555 Long Wharf Drive, New Haven, CT, United States, 06511 What is BioXcel Therapeutics's ISIN number?
BioXcel Therapeutics's international securities identification number is: US09075P1057 What is BioXcel Therapeutics's CUSIP number?
BioXcel Therapeutics's Committee on Uniform Securities Identification Procedures number is: 09075P105
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert